Clinical Trial Update: MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating MenB-FHbp alone or combined with MenACWY-TT in young adults primed with MenB-4C is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenACWY-TT (Meningococcal ACWY tetanus toxoid conjugate vaccine)
• MenB-FHbp (Factor H-binding protein-containing vaccine)

Snippet

Sponsor: Emory University | Conditions: Neisseria Meningitidis | Phase 4 | Status: RECRUITING